Profile data is unavailable for this security.
About the company
KPC Pharmaceuticals Inc is a China-based company primarily engaged in the research, development, manufacturing and sales of pharmaceuticals. The Company operates mainly through two segments. The Pharmaceutical segment focuses on the research and development and manufacturing of drugs for cardiovascular and cerebrovascular treatments, orthopedics, antimalarial drugs, gynecological drugs and digestive system drugs. The Pharmaceutical Wholesale segment is primarily engaged in the wholesale and retail of pharmaceuticals and medical devices. The Company conducts business in both domestic and overseas markets.
- Revenue in CNY (TTM)7.70bn
- Net income in CNY530.05m
- Incorporated1995
- Employees5.28k
- LocationKPC Pharmaceuticals IncNo. 166Keyi Road, High-tech Development ZoneKUNMING 650106ChinaCHN
- Phone+86 87 168324311
- Fax+86 87 168324267
- Websitehttps://www.kpc.com.cn
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Harbin Pharmaceutical Group Co Ltd | 15.94bn | 449.15m | 8.89bn | 9.85k | 19.79 | 1.57 | -- | 0.5577 | 0.1783 | 0.1783 | 6.33 | 2.25 | 1.12 | 5.90 | 3.34 | -- | 3.42 | 1.58 | 8.28 | 4.28 | 25.83 | 24.86 | 3.04 | 1.51 | 1.16 | 17.44 | 0.1628 | 0.00 | 4.65 | 6.47 | 59.10 | 62.32 | 20.92 | -- |
| GuangYuYuan Chinese Herbal Medicn Co Ltd | 1.39bn | 82.37m | 8.89bn | 1.74k | 107.97 | 5.39 | -- | 6.40 | 0.1683 | 0.1683 | 2.84 | 3.37 | 0.5711 | 0.6215 | 4.13 | 800,359.30 | 3.51 | -2.57 | 5.10 | -3.94 | 66.36 | 68.69 | 6.15 | -6.95 | 1.16 | 17.91 | 0.0336 | -- | -4.87 | 0.071 | -17.35 | -10.56 | -36.84 | -- |
| Frontier Biotechnologies Inc | 141.20m | -167.73m | 9.03bn | 302.00 | -- | 9.20 | -- | 63.98 | -0.4478 | -0.4478 | 0.377 | 2.62 | 0.0775 | 1.78 | 2.74 | 467,559.50 | -9.21 | -12.65 | -12.08 | -14.50 | 32.51 | 18.59 | -118.79 | -333.96 | 2.58 | -- | 0.3472 | -- | 13.32 | 44.07 | 38.78 | -- | -35.01 | -- |
| KPC Pharmaceuticals Inc | 7.70bn | 530.05m | 9.45bn | 5.28k | 17.66 | 1.78 | -- | 1.23 | 0.7067 | 0.7067 | 10.21 | 7.01 | 0.6987 | 2.98 | 2.48 | 1,458,805.00 | 6.21 | 5.65 | 11.19 | 9.98 | 41.77 | 43.07 | 8.89 | 6.71 | 1.58 | -- | 0.1981 | 34.63 | -0.3408 | 0.6839 | 19.86 | 7.36 | -25.55 | 8.45 |
| North China Pharmaceutical Co Ltd | 9.79bn | 183.03m | 9.61bn | 10.09k | 52.59 | 1.75 | -- | 0.981 | 0.1065 | 0.1065 | 5.69 | 3.21 | 0.453 | 2.91 | 4.26 | 970,873.20 | 1.30 | -0.2469 | 3.23 | -0.578 | 30.05 | 33.78 | 2.86 | -0.5243 | 0.4902 | 2.22 | 0.6254 | -- | -2.48 | -2.94 | 2,496.80 | -5.90 | 3.21 | 0.00 |
| Shandong Lukang Pharmaceutical Co Ltd | 6.19bn | 188.75m | 9.65bn | 6.39k | 44.18 | 2.10 | -- | 1.56 | 0.2089 | 0.2089 | 6.85 | 4.40 | 0.6891 | 3.69 | 6.77 | 969,079.80 | 2.20 | 2.78 | 3.60 | 5.00 | 22.98 | 22.76 | 3.20 | 4.17 | 0.7984 | 6.01 | 0.4324 | 31.07 | 1.41 | 10.80 | 60.30 | 26.62 | -19.55 | 24.01 |
| Chongqing Taiji Industry Group Co Ltd | 10.04bn | -352.52m | 9.90bn | 11.97k | -- | 2.80 | -- | 0.9859 | -0.8238 | -0.8238 | 18.98 | 6.42 | 0.7032 | 2.85 | 3.55 | 838,688.20 | -2.36 | 0.9924 | -6.94 | 3.04 | 26.30 | 43.37 | -3.35 | 1.08 | 0.4906 | 0.5756 | 0.5914 | 22.39 | -20.72 | 1.24 | -96.76 | -- | -3.36 | -- |
| Chengdu Olymvax Biopharmaceuticals Inc | 709.13m | 64.21m | 9.90bn | 470.00 | 153.74 | 10.32 | -- | 13.96 | 0.1587 | 0.1587 | 1.75 | 2.36 | 0.3883 | 0.654 | 1.19 | 1,508,792.00 | 3.45 | 3.25 | 5.00 | 4.81 | 92.66 | 93.62 | 8.88 | 8.11 | 1.42 | 8.30 | 0.2906 | 7.39 | 18.69 | 26.88 | 18.24 | -- | 48.00 | -- |
Data as of Feb 11 2026. Currency figures normalised to KPC Pharmaceuticals Inc's reporting currency: Chinese Yuan Renminbi CNY
10.24%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 35.25m | 4.66% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 11.93m | 1.58% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 2025 | 10.43m | 1.38% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 5.38m | 0.71% |
| UBS SDIC Fund Management Co., Ltd.as of 30 Jun 2025 | 3.13m | 0.41% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 2.91m | 0.38% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 2.69m | 0.36% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 2.11m | 0.28% |
| Value Partners Ltd.as of 30 Jun 2025 | 2.02m | 0.27% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2025 | 1.67m | 0.22% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
